RPAM
Rhenman & Partners Asset Management’s Nurix Therapeutics NRIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.11M | Sell |
185,000
-64,336
| -26% | -$733K | 0.27% | 71 |
|
|
2025
Q1 | $2.96M | Sell |
249,336
-40,664
| -14% | -$483K | 0.34% | 61 |
|
|
2024
Q4 | $5.46M | Sell |
290,000
-10,000
| -3% | -$188K | 0.56% | 55 |
|
|
2024
Q3 | $6.74M | Buy |
300,000
+125,607
| +72% | +$2.82M | 0.55% | 58 |
|
|
2024
Q2 | $3.64M | Buy |
+174,393
| New | +$3.64M | 0.35% | 65 |
|